News

Newk's Raises more than $110,000 for OCRFA

When Lori Newcomb first visited her doctor for abdominal pain, the last thing she expected to walk out with was a late-stage ovarian cancer diagnosis…

Read on

Zubik v. Burwell & the Supreme Court

FOR IMMEDIATE RELEASE May 17, 2016   Lisa Mauti lmauti@ocrfa.org 202-517-6410 Supreme Court Returns Zubik v…

Read on

Webinar: Clinical Trials: What you need to know

Oliver Dorigo, MD, PhD, Director of the Stanford Gynecologic Oncology Clinical Care Program and Director of Stanford Obstetrics and Gynecology’s Division of Gynecologic Oncology provided an introduction to clinical trials for ovarian cancer…

Read on

Long Term Survival Study Recruiting Participants

The Consortium for Long-Term Survival — is bringing together research groups worldwide…

Read on

OCRFA Research Helps Explain Resistance to Chemotherapy

(May 4, 2016) Research funded in part by an OCRFA research grant to Dr…

Read on

OVARYact

Lauren Richards lost her mom Rochelle Richards to ovarian cancer earlier this year. Lauren set out on a mission to make a difference in her community and to honor her mom’s journey…

Read on

The Vicki Welsh Fund

The Vicki Welsh Fund for Ovarian Cancer began 10 years ago, with the goal of fighting ovarian cancer through awareness, education, research, and support…

Read on

Irregular Periods May Increase Ovarian Cancer Risk

Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life…

Read on

Irregular Periods May Increase Ovarian Cancer Risk

(May 2, 2016) Research published last month in the International Journal of Cancer showed an unexpected finding: young women with irregular menstrual periods may be at higher risk of developing—and dying from—ovarian cancer later in life…

Read on

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards

May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-­‐affiliated scientists…

Read on

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A…

Read on

Hormone Therapy Safe After Nonserous Ovarian Cancer

(April 25, 2016) New findings published online this month in Obstetrics and Gynecology suggest that hormone therapy (HT) can be used safely to manage menopausal symptoms in women who have undergone treatment for nonserous epithelial ovarian cancer…

Read on